Dipeptidyl peptidase 4 (DPP4) inhibitor and outcome from coronavirus disease 2019 (COVID-19) in diabetic patients: a systematic review, meta-analysis, and meta-regression

BACKGROUND: One of the drugs which is commonly used in diabetic patients is Dipeptidyl Peptidase-4 (DPP-4) inhibitor. Currently, the association between DPP-4 inhibitor and coronavirus disease 2019 (COVID-19) outcome is not yet established. This study aims to analyze the potential association betwee...

Descripción completa

Detalles Bibliográficos
Autores principales: Hariyanto, Timotius Ivan, Kurniawan, Andree
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Springer International Publishing 2021
Materias:
Research Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8003892/
https://www.ncbi.nlm.nih.gov/pubmed/33816358
http://dx.doi.org/10.1007/s40200-021-00777-4

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8003892/
https://www.ncbi.nlm.nih.gov/pubmed/33816358
http://dx.doi.org/10.1007/s40200-021-00777-4

Ejemplares similares